Radiation Therapy, Temozolomide, and Erlotinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Clinical trial NCT00274833 · COMPLETED

Trial details

NCT number: NCT00274833
Sponsor: David Peereboom
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

CNS Tumor, Adult

Start date: 2005-10-01
Primary completion: 2007-10-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.